Recent developments in targeting access to high cost medicines in Australia

BACKGROUND: In Australia, the Pharmaceutical Benefits Scheme (PBS) has developed a set of arrangements to control access to high-cost medicines to ensure their use is cost-effective. These medicines include the tumour necrosis factor-alpha inhibitors (TNFIs) for the treatment of rheumatoid arthritis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Christine Y, Ritchie, Jan, Williams, Kenneth M, Day, Richard O
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1325248/
https://www.ncbi.nlm.nih.gov/pubmed/16305742
http://dx.doi.org/10.1186/1743-8462-2-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1325248/
https://www.ncbi.nlm.nih.gov/pubmed/16305742
http://dx.doi.org/10.1186/1743-8462-2-28

Ejemplares similares